Estrogen metabolism and formation of estrogen-DNA adducts in estradiol-treated MCF-10F cells. The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin induction and catechol-O-methyltransferase inhibition

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

Formation of estrogen metabolites that react with DNA is thought to be a mechanism of cancer initiation by estrogens. The estrogens estrone (E1) and estradiol (E2) can form catechol estrogen (CE) metabolites, catechol estrogen quinones [E1(E2)-3,4-Q], which react with DNA to form predominantly depurinating adducts. This may lead to mutations that initiate cancer. Catechol-O-methyltransferase (COMT) catalyzes an inactivation (protective) pathway for CE. This study investigated the effect of inhibiting COMT activity on the levels of depurinating 4-OHE1(E2)-1-N3Ade and 4-OHE1(E2)-1-N7Gua adducts in human breast epithelial cells. MCF-10F cells were treated with TCDD, a cytochrome P450 inducer, then with E2 and Ro41-0960, a COMT inhibitor. Estrogen metabolites and depurinating DNA adducts in culture medium were analyzed by HPLC with electrochemical detection. Pre-treatment of cells with TCDD increased E2 metabolism to 4-OHE1(E2) and 4-OCH3E1(E2). Inclusion of Ro41-0960 and E2 in the medium blocked formation of methoxy CE, and depurinating adducts were observed. With Ro41-0960, more adducts were detected in MCF-10F cells exposed to 1 μM E2, whereas without the inhibitor, no increases in adducts were detected with E2 ≤ 10 μM. We conclude that low COMT activity and increased formation of depurinating adducts can be critical factors leading to initiation of breast cancer.

Original languageEnglish (US)
Pages (from-to)150-158
Number of pages9
JournalJournal of Steroid Biochemistry and Molecular Biology
Volume105
Issue number1-5
DOIs
StatePublished - Jun 1 2007

Fingerprint

Catechol Estrogens
Catechol O-Methyltransferase
DNA Adducts
Metabolism
Estradiol
Estrogens
Metabolites
Quinones
Estrone
DNA
Cytochrome P-450 Enzyme System
Culture Media
Neoplasms
Breast
Epithelial Cells
High Pressure Liquid Chromatography
Cells
Breast Neoplasms
Mutation
1,4-dioxin

Keywords

  • 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)
  • Catechol-O-methyltransferase
  • Depurinating estrogen-DNA adducts
  • Estrogen metabolism
  • MCF-10F cells

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Endocrinology
  • Clinical Biochemistry
  • Cell Biology

Cite this

@article{f0cf3c48aad249d59fc2caa82d4ba941,
title = "Estrogen metabolism and formation of estrogen-DNA adducts in estradiol-treated MCF-10F cells. The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin induction and catechol-O-methyltransferase inhibition",
abstract = "Formation of estrogen metabolites that react with DNA is thought to be a mechanism of cancer initiation by estrogens. The estrogens estrone (E1) and estradiol (E2) can form catechol estrogen (CE) metabolites, catechol estrogen quinones [E1(E2)-3,4-Q], which react with DNA to form predominantly depurinating adducts. This may lead to mutations that initiate cancer. Catechol-O-methyltransferase (COMT) catalyzes an inactivation (protective) pathway for CE. This study investigated the effect of inhibiting COMT activity on the levels of depurinating 4-OHE1(E2)-1-N3Ade and 4-OHE1(E2)-1-N7Gua adducts in human breast epithelial cells. MCF-10F cells were treated with TCDD, a cytochrome P450 inducer, then with E2 and Ro41-0960, a COMT inhibitor. Estrogen metabolites and depurinating DNA adducts in culture medium were analyzed by HPLC with electrochemical detection. Pre-treatment of cells with TCDD increased E2 metabolism to 4-OHE1(E2) and 4-OCH3E1(E2). Inclusion of Ro41-0960 and E2 in the medium blocked formation of methoxy CE, and depurinating adducts were observed. With Ro41-0960, more adducts were detected in MCF-10F cells exposed to 1 μM E2, whereas without the inhibitor, no increases in adducts were detected with E2 ≤ 10 μM. We conclude that low COMT activity and increased formation of depurinating adducts can be critical factors leading to initiation of breast cancer.",
keywords = "2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD), Catechol-O-methyltransferase, Depurinating estrogen-DNA adducts, Estrogen metabolism, MCF-10F cells",
author = "Fang Lu and Muhammad Zahid and Muhammad Saeed and Ercole Cavalieri and Rogan, {Eleanor G}",
year = "2007",
month = "6",
day = "1",
doi = "10.1016/j.jsbmb.2006.12.102",
language = "English (US)",
volume = "105",
pages = "150--158",
journal = "Journal of Steroid Biochemistry and Molecular Biology",
issn = "0960-0760",
publisher = "Elsevier Limited",
number = "1-5",

}

TY - JOUR

T1 - Estrogen metabolism and formation of estrogen-DNA adducts in estradiol-treated MCF-10F cells. The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin induction and catechol-O-methyltransferase inhibition

AU - Lu, Fang

AU - Zahid, Muhammad

AU - Saeed, Muhammad

AU - Cavalieri, Ercole

AU - Rogan, Eleanor G

PY - 2007/6/1

Y1 - 2007/6/1

N2 - Formation of estrogen metabolites that react with DNA is thought to be a mechanism of cancer initiation by estrogens. The estrogens estrone (E1) and estradiol (E2) can form catechol estrogen (CE) metabolites, catechol estrogen quinones [E1(E2)-3,4-Q], which react with DNA to form predominantly depurinating adducts. This may lead to mutations that initiate cancer. Catechol-O-methyltransferase (COMT) catalyzes an inactivation (protective) pathway for CE. This study investigated the effect of inhibiting COMT activity on the levels of depurinating 4-OHE1(E2)-1-N3Ade and 4-OHE1(E2)-1-N7Gua adducts in human breast epithelial cells. MCF-10F cells were treated with TCDD, a cytochrome P450 inducer, then with E2 and Ro41-0960, a COMT inhibitor. Estrogen metabolites and depurinating DNA adducts in culture medium were analyzed by HPLC with electrochemical detection. Pre-treatment of cells with TCDD increased E2 metabolism to 4-OHE1(E2) and 4-OCH3E1(E2). Inclusion of Ro41-0960 and E2 in the medium blocked formation of methoxy CE, and depurinating adducts were observed. With Ro41-0960, more adducts were detected in MCF-10F cells exposed to 1 μM E2, whereas without the inhibitor, no increases in adducts were detected with E2 ≤ 10 μM. We conclude that low COMT activity and increased formation of depurinating adducts can be critical factors leading to initiation of breast cancer.

AB - Formation of estrogen metabolites that react with DNA is thought to be a mechanism of cancer initiation by estrogens. The estrogens estrone (E1) and estradiol (E2) can form catechol estrogen (CE) metabolites, catechol estrogen quinones [E1(E2)-3,4-Q], which react with DNA to form predominantly depurinating adducts. This may lead to mutations that initiate cancer. Catechol-O-methyltransferase (COMT) catalyzes an inactivation (protective) pathway for CE. This study investigated the effect of inhibiting COMT activity on the levels of depurinating 4-OHE1(E2)-1-N3Ade and 4-OHE1(E2)-1-N7Gua adducts in human breast epithelial cells. MCF-10F cells were treated with TCDD, a cytochrome P450 inducer, then with E2 and Ro41-0960, a COMT inhibitor. Estrogen metabolites and depurinating DNA adducts in culture medium were analyzed by HPLC with electrochemical detection. Pre-treatment of cells with TCDD increased E2 metabolism to 4-OHE1(E2) and 4-OCH3E1(E2). Inclusion of Ro41-0960 and E2 in the medium blocked formation of methoxy CE, and depurinating adducts were observed. With Ro41-0960, more adducts were detected in MCF-10F cells exposed to 1 μM E2, whereas without the inhibitor, no increases in adducts were detected with E2 ≤ 10 μM. We conclude that low COMT activity and increased formation of depurinating adducts can be critical factors leading to initiation of breast cancer.

KW - 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)

KW - Catechol-O-methyltransferase

KW - Depurinating estrogen-DNA adducts

KW - Estrogen metabolism

KW - MCF-10F cells

UR - http://www.scopus.com/inward/record.url?scp=34547697291&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547697291&partnerID=8YFLogxK

U2 - 10.1016/j.jsbmb.2006.12.102

DO - 10.1016/j.jsbmb.2006.12.102

M3 - Article

VL - 105

SP - 150

EP - 158

JO - Journal of Steroid Biochemistry and Molecular Biology

JF - Journal of Steroid Biochemistry and Molecular Biology

SN - 0960-0760

IS - 1-5

ER -